10.1002/ejoc.201900136
European Journal of Organic Chemistry
FULL PAPER
A solution of (E)-4-((4-((6A-deoxy--cyclodextrin-6A-yl)carbamoyl)phenyl)
diazenyl)benzoic acid (1.11 g, 0.91 mmol), tert-butyl (3-aminopropyl)
carbamate (0.25 g, 1.4 mmol), BOP (0.49 g, 1.1 mmol) and Et3N (0.1 mL,
0.72 mmol) in anhydrous DMF (15 mL) was stirred overnight at room
temperature, before it was added drop-wise into ice-cooled acetone (0.5
L), with stirring. The orange precipitate that formed was separated by
centrifugation, washed with acetone (5 × 200 mL), and dried under
vacuum, before it was dissolved in water (0.5 L). The solution was
applied to a Diaion HP-20 column (185 x 45 mm). The column was then
eluted with water (1 L), followed by a gradient of methanol-water. The
starting material eluted with 5-40% methanol, while the title compound
eluted with 45-80% methanol. Fractions containing this material were
combined and lyophilized to give an orange powder (1.02 g, 81%). Rf =
0.74 (n-butanol/ethanol/water 5:4:3); 1H NMR (400 MHz, D2O): δ = 8.52
(d, J = 8.0 Hz, 2H), 8.19 (d, J = 8.0 Hz, 2H), 7.74 (d, J = 8.2 Hz, 2H), 7.69
(d, J = 8.2 Hz, 2H), 5.16–4.87 (m, 6H), 4.31–3.14 (m, 40H), 1.88 (m, 2H),
1.47 (s, 9H); HRMS (ESI): m/z calcd for C58H86N5O33 [M+H]+ 1380.5205,
found 1380.5212.
Cyclodextrin monomer 8. HPLC: tR 8.0 min, max 332 nm; 1H NMR (400
MHz, D2O): δ = 8.52 (d, J = 8.1 Hz, 2H), 8.19 (d, J = 8.1 Hz, 2H), 7.74 (d,
J = 8.1 Hz, 2H), 7.69 (d, J = 8.1 Hz, 2H), 5.20–4.90 (m, 6H), 4.40–2.90
(m, 40H), 2.41 (t, J = 7.3 Hz, 2H, -CH2CH2CH2CO2H), 2.30 (t, J = 7.3 Hz,
2H, -CH2CH2CH2CONH-), 1.95–1.85 (m, 2H, -CONHCH2CH2CH2NHCO-),
1.71–1.58 (m, 4H, -CH2CH2CH2CO-), 1.40–1.33 (m, 4H,
-
CH2CH2CH2CO-); MALDI-TOF MS: m/z calcd for C61H89N5O34Na
[M+Na]+ 1459, found 1460; HRMS (ESI): m/z calcd for C61H88N5O34 [M-
H]- 1434.5316, found 1434.5312.
1
Linear tetrameric daisy chain 9a. HPLC: tR 16.2 min, max 342 nm; H
NMR (600 MHz, D2O): δ = 8.55 (d, J = 8.2 Hz, 8H), 8.23 (d, J = 8.2 Hz,
8H), 7.77 (d, J = 8.2 Hz, 8H), 7.72 (d, J = 8.2 Hz, 8H), 5.21–4.87 (m,
24H), 4.34–2.99 (m, 160H), 2.34 (t, J = 7.4 Hz, 4H, -CH2CH2CH2CONH-),
2.13–2.08 (m, 4H, -CONHCH2CH2CH2NH2), 1.97–1.91 (m, 4H,
-
CONHCH2CH2CH2NHCO-), 1.72–1.65 (m, 4H, -CH2CH2CH2CO-), 1.42–
1.38 (m, 4H, -CH2CH2CH2CO-); MALDI-TOF MS: m/z calcd for
C220H318N20O126Na [M+Na]+ 5282, found 5286; HRMS (ESI): m/z calcd
for C220H319N20O126 [M+H]+ 5259.9264, found 5259.9455.
(E)-N-(3-Aminopropyl)-4-((4-((6A-deoxy--cyclodextrin-6A-
yl)carbamoyl)phenyl)diazenyl)benzamide (3a)
1
Linear tetrameric daisy chain 9b. HPLC: tR 16.9 min, max 340 nm; H
NMR (600 MHz, D2O): δ = 8.55 (d, J = 8.0 Hz, 8H), 8.23 (d, J = 8.0 Hz,
8H), 7.77 (d, J = 8.0 Hz, 8H), 7.72 (d, J = 8.0 Hz, 8H), 5.20–4.88 (m,
24H), 4.40–3.00 (m, 160H), 2.44 (t, J = 7.4 Hz, 2H, -CH2CH2CH2CO2H),
2.34 (t, J = 7.4 Hz, 6H, -CH2CH2CH2CONH-), 2.13–2.08 (m, 2H, -
CONHCH2CH2CH2NH2), 1.97–1.91 (m, 6H, -CONHCH2CH2CH2NHCO-),
A
solution of (E)-tert-butyl (3-(4-((4-((6A-deoxy--cyclodextrin-6A-
yl)carbamoyl)phenyl)diazenyl)benzamido)-propyl)carbamate (0.20 g,
0.15 mmol) in TFA (10 mL) cooled to 5 °C was stirred for 1.5 h, before it
was concentrated under vacuum to dryness, to give a red film. The film
was washed with diethyl ether (3 x 5 mL) to obtain a fine precipitate,
which was dried under vacuum overnight, to give the trifluoroacetate salt
of the title compound as an orange powder (170 mg, 81%). Rf = 0.14 (i-
propanol/ethanol/water/acetic acid 5:4:3:2); m.p. 219-223 °C (dec.); 1H
NMR (400 MHz, D2O): δ = 8.53 (d, J = 8.0 Hz, 2H), 8.20 (d, J = 8.0 Hz,
2H), 7.74 (d, J = 8.2 Hz, 2H), 7.69 (d, J = 8.2 Hz, 2H), 5.16–4.86 (m, 6H),
4.32–2.81 (m, 40H), 2.12–2.00 (m, 2H); HRMS (ESI): m/z calcd for
C53H78N5O31 [M+H]+ 1280.4681, found 1280.4688; HPLC: tR 18.1 min
(column: Agilent Zorbax SB C18 3.5 μm, 150 x 4.6 mm, eluent gradient
MeCN/H2O (0.1% TFA) – MeCN 5% 0-3 min, 5-47% 3-20 min, 47% 20-
30 min, flow rate 1 mL min-1); HPLC: tR 4.2 min (column: Grace Prevail
Carbohydrate ES 9 µm, 300 x 20 mm, eluent gradient MeCN/H2O (0.1%
TFA) – MeCN 70-60% 0-40 min, 60-30% 40-45 min, 30% 45-60 min, flow
rate 10 mL min-1).
1.72–1.65 (m, 8H, -CH2CH2CH2CO-), 1.42–1.38 (m, 8H,
-
CH2CH2CH2CO-); MALDI-TOF MS: m/z calcd for C228H330N20O129Na
[M+Na]+ 5438, found 5437; HRMS (ESI): m/z calcd for C228H331N20O129
[M+H]+ 5416.0051, found 5416.0273.
Linear tetrameric daisy chain 10a. HPLC: tR 15.7 min, max 343 nm; 1H
NMR (400 MHz, D2O): δ = 8.52 (d, J = 8.0 Hz, 8H), 8.20 (d, J = 8.0 Hz,
8H), 7.74 (d, J = 8.0 Hz, 8H), 7.68 (d, J = 8.0 Hz, 8H), 5.20–4.88 (m,
24H), 4.36–2.97 (m, 160H), 2.40 (t, J = 7.4 Hz, 4H, -CH2CH2CH2CO2H),
2.30 (t, J = 7.4 Hz, 8H, -CH2CH2CH2CONH-), 1.95–1.86 (m, 8H, -
CONHCH2CH2CH2NHCO-), 1.70–1.58 (m, 12H, -CH2CH2CH2CO-), 1.42–
1.31 (m, 12H, -CH2CH2CH2CO-); MALDI-TOF MS: m/z calcd for
C236H342N20O132Na [M+Na]+ 5594, found 5591; HRMS (ESI): m/z calcd
for C236H343N20O132 [M+H]+ 5572.0830, found 5572.0961.
Reaction of (E)-N-(3-aminopropyl)-4-((4-((6A-deoxy--cyclodextrin-
6A-yl)carbamoyl)phenyl)diazenyl)-benzamide (3a) with suberic acid
bis(3-sulfonato-N-hydroxysuccinimide ester) disodium salt (7)
Linear hexameric daisy chain 10b. HPLC: tR 21.7 min, max 342 nm; 1H
NMR (400 MHz, D2O): δ = 8.52 (d, J = 8.0 Hz, 12H), 8.19 (d, J = 8.0 Hz,
12H), 7.73 (d, J = 8.0 Hz, 12H), 7.68 (d, J = 8.0 Hz, 12H), 5.20–4.88 (m,
36H), 4.33–2.95 (m, 240H), 2.40 (t, J = 7.4 Hz, 4H, -CH2CH2CH2CO2H),
2.31 (t, J = 7.4 Hz, 12H, -CH2CH2CH2CONH-), 1.95–1.87 (m, 12H, -
CONHCH2CH2CH2NHCO-), 1.70–1.58 (m, 16H, -CH2CH2CH2CO-), 1.41–
1.32 (m, 16H, -CH2CH2CH2CO-); MALDI-TOF MS: m/z calcd for
C350H506N30O196Na [M+Na]+ 8293, found 8290; HRMS (ESI): m/z calcd
for C350H507N30O196 [M+H]+ 8270.0746, found 8270.0883.
In a representative reaction, the trifluoroacetate salt of the cyclodextrin
3a (80 mg, 62 μmol, 120 mM) was added to pH 9.5 carbonate buffer (0.5
mL, 100 mM), and the mixture was stirred at room temperature for 15
min. The suberic acid derivative 7 (22 mg, 38 μmol, 0.6 equiv.) was then
added, and stirring was continued at room temperature for 3 days. HPLC
analysis of the product mixture (Figure 6) after that time showed the
presence of the unreacted starting material 3a, its suberic acid derivative
8, the cyclodextrin tetramers 9b and 10a, the oligomers 10b, 10c and
10d, the cyclic dimer 11 and a tetrameric species 12. Samples of 8, 9b,
10a-10d, 11 and 12 were isolated using preparative HPLC. When the
reaction product was analyzed after 1 day instead of 3, HPLC analysis
showed the presence of 3a, 8, and the cyclodextrin tetramers 9a and 9b.
A sample of 9a was also isolated using preparative HPLC. HPLC was
carried out using a Grace Prevail Carbohydrate ES 9 µm (300 x 20 mm)
column, with a gradient eluent of MeCN/H2O (0.1% TFA) – MeCN 70-
60% 0-40 min, 60-30% 40-45 min, 30% 45-60 min, at a flow rate of 10
mL min-1, monitoring at 352 nm.
Linear octameric daisy chain 10c. HPLC: tR 26.7 min, max 342 nm; 1H
NMR (400 MHz, D2O): δ = 8.52 (d, J = 8.0 Hz, 16H), 8.19 (d, J = 8.0 Hz,
16H), 7.73 (d, J = 8.0 Hz, 16H), 7.68 (d, J = 8.0 Hz, 16H), 5.16–4.93 (m,
48H), 4.33–2.95 (m, 320H), 2.40 (t, J = 7.4 Hz, 4H, -CH2CH2CH2CO2H),
2.30 (t, J = 7.4 Hz, 16H, -CH2CH2CH2CONH-), 1.95–1.86 (m, 16H, -
CONHCH2CH2CH2NHCO-), 1.70–1.59 (m, 20H, -CH2CH2CH2CO-), 1.42–
1.33 (m, 20H, -CH2CH2CH2CO-); MALDI-TOF MS: m/z calcd for
C464H670N40O260Na [M+Na]+ 10991, found 10986; HRMS (ESI): m/z calcd
for C464H671N40O260 [M+H]+ 10968.0676, found 10968.1170.
Linear decameric daisy chain 10d. HPLC: tR 32.0 min, max 341 nm; 1H
NMR (400 MHz, D2O): δ = 8.51 (d, J = 8.0 Hz, 20H), 8.19 (d, J = 8.0 Hz,
This article is protected by copyright. All rights reserved.